Managing multiple sclerosis (MS) by therapy may essentially be divided into three areas of focus: treating the acute relapse, managing symptoms and targeting disease pathology. The gold standard for treating a MS exacerbation has remained unchanged over recent years. Generally, most clinicians recommend three to five days of intravenous methyhlprednisolone which may or may not be followed by a course of oral prednisone. The decision to use the addition of oral prednisone is usually dependent on...

